These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 810574)
1. Metabolic disposition and cardiovascular effects of methyldopate in unanesthetized rhesus monkeys. Walson PD; Marshall KS; Forsyth RP; Rapoport R; Melmon KL; Castagnoli N J Pharmacol Exp Ther; 1975 Oct; 195(1):151-8. PubMed ID: 810574 [TBL] [Abstract][Full Text] [Related]
2. Plasma concentration of alpha-methyldopa and sulphate conjugate after oral administration of methyldopa and intravenous administration of methyldopa and methyldopa hydrochloride ethyl ester. Saavedra JA; Reid JL; Jordan W; Rawlins MD; Dollery CT Eur J Clin Pharmacol; 1975 Aug; 8(6):381-6. PubMed ID: 1233238 [TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of systemic and central administration of alpha-methyldopa. Forsyth RP; Bolme P; Ishizaki T; Melmon KL J Pharmacol Exp Ther; 1978 Jun; 205(3):675-82. PubMed ID: 96250 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate. Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of succinimidoethyl and pivaloyloxyethyl esters as progenitors of methyldopa in man, rhesus monkey, dog, and rat. Vickers S; Duncan CA; White SD; Breault GO; Royds RB; de Schepper PJ; Tempero KF Drug Metab Dispos; 1978; 6(6):640-6. PubMed ID: 33026 [TBL] [Abstract][Full Text] [Related]
6. Contribution of central and peripheral mechanisms to the antihypertensive effects of alpha-methyldopa in the rabbit. Bobik A; Badoer E; Oddie C; Head G; Korner P J Cardiovasc Pharmacol; 1984; 6(6):1109-14. PubMed ID: 6084767 [TBL] [Abstract][Full Text] [Related]
7. Effects of alpha-methyldopa on blood pressure in the anaesthetized dog. Blower PR; Poyser RH; Robertson MI J Pharm Pharmacol; 1976 May; 28(5):437-40. PubMed ID: 6754 [TBL] [Abstract][Full Text] [Related]
8. alpha-Methyldopamine, a key intermediate in the metabolic disposition of 3,4-methylenedioxyamphetamine in vivo in dog and monkey. Midha KK; Hubbard JW; Bailey K; Cooper JK Drug Metab Dispos; 1978; 6(6):623-30. PubMed ID: 33023 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular and respiratory responses to ketamine hydrochloride in the rhesus monkey (Macaca mulatta). Ochsner AJ Lab Anim Sci; 1977 Feb; 27(1):69-71. PubMed ID: 850390 [TBL] [Abstract][Full Text] [Related]
10. Sensitive high-performance liquid chromatographic assay using electrochemical detection for a novel prodrug ester of methyldopa, pivaloyloxyethyl 3-(3,4-dihydroxyphenyl)-2-methylalaninate, in plasma and urine. Musson DG; Vincek WC; Dobrinska MR; Vickers S; Leidy HL J Chromatogr; 1984 Jun; 308():251-9. PubMed ID: 6746818 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey. Adams WJ; McGovren JP; Dalm EA; Brewer JE; Hosley JD Cancer Res; 1989 Nov; 49(22):6328-36. PubMed ID: 2529962 [TBL] [Abstract][Full Text] [Related]
13. Proceedings: Possible mechanism of action of methyldopa: relationship studies between route on administration, dose, plasma concentration and hemodynamic changes in conscious monkeys. Ishizaki T; Forsyth RP; Melmon KL Jpn J Pharmacol; 1974; 24(0):s:119. PubMed ID: 4209044 [No Abstract] [Full Text] [Related]
14. Differential blood pressure responses to intracisternal clonidine, alpha-methyldopa, and 6-hydroxydopamine in conscious normotensive and spontaneously hypertensive rats. Head GA; de Jong W J Cardiovasc Pharmacol; 1986; 8(4):735-42. PubMed ID: 2427812 [TBL] [Abstract][Full Text] [Related]
15. Determination of methyldopa in plasma using high-performance liquid chromatography with electrochemical detection. Application to pharmacokinetic/bioavailability studies. Dilger C; Salama Z; Jaeger H Arzneimittelforschung; 1987 Dec; 37(12):1399-401. PubMed ID: 3449071 [TBL] [Abstract][Full Text] [Related]
16. The effects of horizontal body casting on blood volume, drug responsiveness, and +Gz tolerance in the Rhesus monkey. Dickey DT; Billman GE; Teoh K; Sandler H; Stone HL Aviat Space Environ Med; 1982 Feb; 53(2):142-6. PubMed ID: 7059330 [TBL] [Abstract][Full Text] [Related]
17. Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studies. Prueksaritanont T; Gorham LM; Ellis JD; Fernandez-Metzler C; Deluna P; Gehret JR; Strong KL; Hochman JH; Askew BC; Duggan ME; Gilbert JD; Lin JH; Vyas KP Drug Metab Dispos; 1996 Nov; 24(11):1263-71. PubMed ID: 8937862 [TBL] [Abstract][Full Text] [Related]
18. Metabolism of methyldopa in man after oral administration of the pivaloyloxyethyl ester. Vickers S; Duncan CA; Ramjit HG; Dobrinska MR; Dollery CT; Gomez HJ; Leidy HL; Vincek WC Drug Metab Dispos; 1984; 12(2):242-6. PubMed ID: 6144491 [TBL] [Abstract][Full Text] [Related]
19. Rapid resolution liquid chromatography-mass spectrometry determination of SAR97276 in monkey matrices. Pharmacokinetics in rhesus monkey infected by Plasmodium cynomolgi. Margout D; Bontemps N; Kocken CH; Vial HJ; Bressolle FM J Pharm Biomed Anal; 2009 Jul; 49(5):1266-71. PubMed ID: 19303732 [TBL] [Abstract][Full Text] [Related]
20. Excretion and metabolism of recainam, a new anti-arrhythmic drug, in laboratory animals and humans. Scatina JA; Wells DS; Kimmel HB; Kemper CJ; Sisenwine SF Drug Metab Dispos; 1990; 18(5):746-52. PubMed ID: 1981731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]